These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21667555)

  • 1. [Diagnosis of thromboembolic risk in patients with atrial fibrillation].
    Geisler T; Gawaz M
    MMW Fortschr Med; 2011 Apr; 153(15):25-6. PubMed ID: 21667555
    [No Abstract]   [Full Text] [Related]  

  • 2. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
    Apostolakis S; Shantsila E; Lip GY; Lane DA
    Thromb Haemost; 2009 Nov; 102(5):914-5. PubMed ID: 19888529
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anticoagulation: seniors neglected?].
    Füessl HS
    MMW Fortschr Med; 2009 Apr; 151(16):28. PubMed ID: 19658291
    [No Abstract]   [Full Text] [Related]  

  • 4. Silent cerebral embolism during catheter ablation of atrial fibrillation: how concerned should we be?
    Michaud GF
    Circulation; 2010 Oct; 122(17):1662-3. PubMed ID: 20937971
    [No Abstract]   [Full Text] [Related]  

  • 5. Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation.
    Pieri A; Lopes TO; Gabbai AA
    Int J Stroke; 2011 Oct; 6(5):466. PubMed ID: 21951414
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Sep; 18(9):919-24. PubMed ID: 16153514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies to improve uptake of modalities for reducing embolic risk.
    Jolobe OM
    Eur J Intern Med; 2011 Jun; 22(3):e18; author reply e19. PubMed ID: 21570631
    [No Abstract]   [Full Text] [Related]  

  • 8. [Embolism prevention in atrial fibrillation with heparin?].
    Hoppe UC
    Dtsch Med Wochenschr; 2002 Dec; 127(50):2696. PubMed ID: 12481244
    [No Abstract]   [Full Text] [Related]  

  • 9. [Atrial fibrillation. Epidemiology and physiopathology].
    Iuliano L; Micheletta F
    Haematologica; 2001 Sep; 86(9 Suppl):1-4. PubMed ID: 11759617
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards.
    Marcucci M; Iorio A; Nobili A; Tettamanti M; Pasina L; Marengoni A; Salerno F; Corrao S; Mannucci PM;
    Eur J Intern Med; 2010 Dec; 21(6):516-23. PubMed ID: 21111937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial fibrillation: the ancient conundrum defies simple solution.
    Goldman ME; Croft LB
    J Am Coll Cardiol; 2005 Jun; 45(11):1813-4. PubMed ID: 15936611
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulation in the elderly--a thin line between benefit and risk].
    Steffel J; Lüscher TF
    MMW Fortschr Med; 2009 Apr; 151(16):33-6. PubMed ID: 19658293
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticoagulation in atrial fibrillation].
    Burkhard-Meier C; Deutsch HJ; Erdmann E
    Dtsch Med Wochenschr; 2000 Oct; 125(42):1267-71. PubMed ID: 11098239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Atrial fibrillation, comorbidities and new anticoagulants].
    De Decker L; Gegu M; Chevalet P; Berrut G
    Geriatr Psychol Neuropsychiatr Vieil; 2013 Dec; 11(1 Suppl):10-6. PubMed ID: 24463059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging.
    Bernhardt P; Schmidt H; Hammerstingl C; Lüderitz B; Omran H
    J Am Soc Echocardiogr; 2005 Jun; 18(6):649-53. PubMed ID: 15947768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial fibrillation as end point of hypertension. Can antihypertensive therapy prevent it?].
    Geller JC
    MMW Fortschr Med; 2003 Nov; 145(47):38-41. PubMed ID: 14725032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticoagulatin in atrial fibrillation--status of therapy in a network of physicians].
    Marty T; Hurni R; Zoller M; Steiger U; Steurer J; Eichler K
    Praxis (Bern 1994); 2003 Apr; 92(17):801-8. PubMed ID: 12768814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Underutilization of oral anticoagulant therapy for stroke prevention in elderly patients with heart failure.
    Ibrahim SA; Kwoh CK
    Am Heart J; 2000 Aug; 140(2):219-20. PubMed ID: 10925333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study.
    Pérez-Gómez F; Alegría E; Berjón J; Iriarte JA; Zumalde J; Salvador A; Mataix L;
    J Am Coll Cardiol; 2004 Oct; 44(8):1557-66. PubMed ID: 15489085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.